CPHI 2025
Event siteNoventure will attend the CPHI (Frankfurt, 28-30 October 2025)
Arrange a meeting with us to learn more about our products and license availability in the different countries.
¡Meet us at our Stand #4.1L30!
Contact us: https://noventure.com/contact-us
euroPLX 88
Event siteNoventure will attend the euroPLX-88 to be held in Lisbon, Portugal 2-3 June 2025.
Arrange a meeting with us to learn more about our products and license availability in the different countries.
Contact us: https://noventure.com/contact-us
Europharm International Business Meeting 2025
Event siteNoventure will attend Europharm, in Athens, Greece, on 10-11 April 2025.
Arrange a meeting with us to learn more about our products and license availability in the different countries.
Contact us: https://noventure.com/contact-us
euroPLX 87
Event siteNoventure will attend the euroPLX-87 that will take place in Vienna, Austria 10-11 March 2025.
Arrange a meeting with us to learn more about our products and license availability in the different countries.
Contact us: https://noventure.com/contact-us
Tasectan and Xilaplus in the new German GPGN Guidelines
Getting into treatment guidelines is lengthy, especially for new products that need time to gather sufficient scientific and real-life evidence.
For this reason, we are glad to announce that Noventure´s mucoprotectants gelatin tannate and xyloglucan have been mentioned on good terms in the new guideline of the German Society for Pediatric Gastroenterology and Nutrition, “Acute infectious gastroenteritis in infants, children, and adolescents"*.